Previous Close | 0.1910 |
Open | 0.2050 |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's Range | 0.1910 - 0.1910 |
52 Week Range | 0.1200 - 2.1700 |
Volume | |
Avg. Volume | 39,496 |
Market Cap | 6.377M |
Beta (5Y Monthly) | 0.24 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.0990 |
Earnings Date | Mar 28, 2022 - Apr 01, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
LAS VEGAS, June 06, 2022 (GLOBE NEWSWIRE) -- MusclePharm Corporation (“MusclePharm” or the “Company”) (OTCPINK: MSLP), a global provider of leading sports nutrition and lifestyle branded nutritional supplements, today announced that it has entered into a definitive agreement with certain institutional and accredited investors pursuant to which the Company has increased its October 2021 offering to provide for the issuance and sale of an additional Senior Secured Notes and warrants (the “Offering
LAS VEGAS, May 24, 2022 (GLOBE NEWSWIRE) -- MusclePharm Corporation (“MusclePharm” or the “Company”) (OTCMKTS: MSLP), a global provider of leading sports nutrition and lifestyle branded nutritional supplements, today announced that Ryan Drexler, the Company’s Chief Executive Officer, and Sabina Rizvi, the Company’s President and Chief Financial Officer, will be presenting at the LD Micro Invitational XII Conference, to be held June 7-9, 2022 at Four Seasons Westlake Village. The MusclePharm inve
Company Revenue Increases 31% Sequentially to $13.1 Million in First Quarter of 2022 Second Consecutive Quarter of Margin Improvement Despite Industry-Wide Supply Challenges Company Triples MP Performance Energy Sales in First Quarter of 2022 from Fourth Quarter of 2021 to Over $1.1 Million; Delivers Energy Margins of 35% in First Quarter of 2022 LAS VEGAS, May 16, 2022 (GLOBE NEWSWIRE) -- MusclePharm Corporation (“MusclePharm” or the “Company”) (OTCMKTS: MSLP), a global provider of leading spor